EP Wealth Advisors LLC purchased a new stake in shares of Envista Holdings Corporation (NYSE:NVST – Free Report) during the second quarter, Holdings Channel reports. The fund purchased 24,379 shares of the company’s stock, valued at approximately $642,000.
Several other institutional investors and hedge funds have also modified their holdings of the business. Millennium Management LLC boosted its holdings in Envista by 1,442.7% in the fourth quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock worth $52,552,000 after purchasing an additional 2,263,712 shares in the last quarter. Holocene Advisors LP acquired a new position in Envista during the second quarter worth $43,936,000. Arrowstreet Capital Limited Partnership raised its holdings in Envista by 341.5% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock valued at $72,515,000 after buying an additional 2,210,847 shares in the last quarter. Norges Bank bought a new position in Envista during the fourth quarter valued at about $45,113,000. Finally, Alliancebernstein L.P. raised its holdings in Envista by 34.0% during the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock valued at $119,164,000 after buying an additional 1,547,656 shares in the last quarter.
Envista Stock Performance
Shares of NVST opened at $27.34 on Tuesday. The company has a market capitalization of $4.39 billion, a PE ratio of 47.15, a price-to-earnings-growth ratio of 1.30 and a beta of 0.86. Envista Holdings Corporation has a one year low of $18.77 and a one year high of $30.42. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.43 and a quick ratio of 2.07. The company’s fifty day moving average price is $26.95 and its 200 day moving average price is $26.33.
Analysts Set New Price Targets
Several research firms have recently issued reports on NVST. Weiss Ratings upgraded Envista from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 6th. Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Piper Sandler reissued a “neutral” rating and issued a $28.00 price objective (up from $26.00) on shares of Envista in a research note on Thursday, August 6th. Zacks Research upgraded Envista from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. Finally, Evercore reaffirmed an “outperform” rating and set a $33.00 target price on shares of Envista in a research report on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $29.31.
Get Our Latest Stock Report on Envista
Insider Activity at Envista
In related news, SVP Mischa Reis sold 8,000 shares of the business’s stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $27.50, for a total transaction of $220,000.00. Following the completion of the transaction, the senior vice president owned 27,321 shares of the company’s stock, valued at approximately $751,327.50. The trade was a 22.65% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.99% of the company’s stock.
Envista Profile
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Featured Stories
- Five stocks we like better than Envista
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
